Troxevasin, gel 2% 100 g

Pharmacotherapeutic group: Venotonizing and venoprotective agent.

The ATC code is C05CA04.

Pharmacological properties:

Pharmacodynamics:

Troxevasin^â is a flavonoid (rutin derivative). It has P-vitamin activity; it has venotonic, venoprotective, anti-edema, anti-inflammatory, anti-clotting and antioxidant effects. Reduces the permeability and fragility of capillaries, increases their tone. Increases the density of the vascular wall, reduces the exudation of the liquid part of the plasma and diapedesis of blood cells.

Limits inflammation in the vascular wall by limiting platelet adhesion to its surface.

Pharmacokinetics:

When the gel is applied to the affected area, the active ingredient quickly penetrates through the epidermis, after 30 minutes is found in the dermis and after 2-5 hours in the subcutaneous fatty tissue.

Indications

– Varicose leg veins;

– Chronic venous insufficiency with manifestations such as: Swelling, pain, feeling of heaviness in the legs;

– Superficial thrombophlebitis, periphlebitis, phlebothrombosis;

– Postthrombotic syndrome;

– Postthrombotic edema, hematomas;

– Prevention of complications after operations on the veins.

Active ingredient

Troxerutin

Composition

100 g of the gel contain:
Active ingredient: troxerutin 2.0 g;
Excipients: carbomer 0.60 g, trolamine (triethanolamine) 0.70 g, disodium edetate dihydrate 0.05 g, benzalkonium chloride 0.10 g, purified water 96.55 g.
Description: Yellow to light brown gel.

How to take, the dosage

Externally!

Unless otherwise advised by the doctor, a 1-3 cm strip of gel (depending on the surface area affected) is applied in a thin layer to the affected area twice a day in the morning and evening, gently rubbing in until completely absorbed. If necessary, the gel can be applied under an occlusive dressing.

It is recommended to be combined with the intake of Troxevasin capsules ^® for a stronger effect.

If after 6-7 days of treatment no improvement or if symptoms worsen or new symptoms develop, a doctor should be consulted.

To use the drug only according to the indication, route of administration, and dosage listed in the leaflet.

Interaction

There are currently no data on drug interactions of Troxevasin®.

Special Instructions

The gel is to be applied only to an intact surface.

Avoid contact with open wounds, eyes and mucous membranes!

In conditions with increased vascular permeability (including scarlet fever, flu, measles, allergic reactions) the gel is used in combination with ascorbic acid to increase its effect.

The maximum time and recommended doses should not be exceeded if the drug is used alone.

Physician should be seen if there is no reduction or if symptoms worsen.

Effects on the ability to drive vehicles, machinery

Troxevasin® gel has no effect on the ability to drive a vehicle and operate moving machinery.

Synopsis

The gel is yellow to light brown in color.

Contraindications

– Hypersensitivity to the drug;

– Disruption of the integrity of the skin;

– Children under 18 years of age (not enough experience in clinical use).

With caution

– Chronic renal failure (with long-term use).

If you have any of the above conditions, you should consult your doctor before using the drug.

Side effects

Immune system disorders: rarely – urticaria, eczema, dermatitis. If you have side effects mentioned in the instructions, or they worsen, or if you notice any other side effects not mentioned in the instructions, please inform your doctor.

Overdose

Cases of overdose during local use of troxerutin have not been described. In case of accidental ingestion of a large amount of gel it is necessary to take general measures to eliminate the drug from the body (vomiting agents) and consult a physician. Peritoneal dialysis is performed if indicated. In case of overdose of the drug it is necessary to consult a physician.

Pregnancy use

Pregnancy

In the first trimester of pregnancy, use of the drug is contraindicated due to lack of experience in clinical use. In II and III trimesters of pregnancy the drug may be used if the expected benefits to the mother exceed the potential risk to the fetus. It is necessary to consult the physician before using the drug in the second and third trimesters of pregnancy.

Breast-feeding period

There are no data on penetration of troxerutin into breast milk. The drug should not be used during breastfeeding.

Similarities

Troxerutin Vramed, Troxerutin Vetprom, Troxevasin, Troxerutin